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Abstract
Background: Vitamin D has a wide variety of physiological functions in the human body. There is
increasing evidence that low serum levels of this vitamin have an important role in the pathogenesis
of different skeletal and extra-skeletal diseases. Vitamin D deficiency and insufficiency is common
at northern latitudes. There are few population-based studies in the northern European region
looking at the issue in a wider age group. We aimed to measure Vitamin D level in the general
population of Estonia (latitude 59°N), a North-European country where dairy products are not
fortified with vitamin D.
Methods: The study subjects were a population-based random selection of 367 individuals (200
women and 167 men, mean age 48.9 ± 12.2 years, range 25–70 years) from the registers of general
health care providers. 25-(OH) vitamin D (25(OH)D) level and parathyroid hormone (PTH) were
measured in summer and in winter. Additionally age, sex, body mass index (BMI) and self-reported
sunbathing habits were recorded.
Results: The mean serum 25(OH)D concentration in winter was 43.7 ± 15 nmol/L and in summer
59.3 ± 18 nmol/L (p < 0.0001). In winter 73% of the subjects had 25(OH)D insufficiency (25(OH)D
concentration below 50 nmol/L) and 8% had deficiency (25(OH)D below 25 nmol/L). The
corresponding percentages in summer were 29% for insufficiency and less than 1% for deficiency.
PTH reached a plateau at around 80 nmol/L. BMI and age were inversely associated with 25(OH)D,
but lost significance when adjusted for sunbathing habits. A difference in the seasonal 25(OH)D
amplitude between genders (p = 0.01) was revealed.
Conclusion: Vitamin D insufficiency is highly prevalent throughout the year in a population
without vitamin D dairy fortification living at the latitude of 59°N.
Background
Vitamin D plays an important role in calcium and bone
metabolism. Low levels of vitamin D lead to compensa-
tory elevation of parathyroid hormone (PTH), which can
cause lowering of bone mineral density (BMD) and even-
tually osteoporosis with fragility fractures or osteomala-
cia. Epidemiological studies have demonstrated a
predisposition of the individuals with low levels of vita-
min D to certain extra-skeletal diseases [1-4].
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worldwide [5,6]. This shortcoming in vitamin D status is
most prevalent in the elderly population, but affects peo-
ple of all age groups [7-9]. Vitamin D serum concentra-
tions are influenced by several modifiable and non-
modifiable factors such as diet, latitude, season, time out-
doors, skin pigmentation, clothing and tanning habits
[10,11]. At high northern latitudes (above 40°N) even
with adequate sun exposure the dermal generation of vita-
min D is low or missing in winter and thus increases
demand for dietary intake [5,12]. As very few foods natu-
rally contain vitamin D in amounts satisfying such
increased demand in winter, this results in marked sea-
sonal variation in the levels of vitamin D [13]. It has been
hypothesised that annually recurring cycles of vitamin D
can cause mild secondary hyperparathyroidism, which
leads to variations in bone turnover rate [14]. Such fluctu-
ations could influence the rate of age-related bone loss
[15] and might hamper peak bone mass attainment [16].
Different cut-off values for the normal threshold for vita-
min D have been used until recently. A level of 50 nmol/
L has been widely used to define 25(OH)D insufficiency,
while some studies have used 37.5 nmol/L as the lowest
level of sufficiency [17-19]. Recent studies, however, sug-
gest that a 25-(OH)D level as high as 75 nmol/L or higher
is needed to cover all physiological functions of vitamin D
and should therefore be considered optimal [7,20-23].
There are wide regional differences in the 25(OH)D levels
with an observed latitude effect, which has already been
addressed in several countries by implementing dairy for-
tifications policies. Therefore, Norway and Sweden, two
of the northernmost countries in Europe, have population
25(OH)D serum levels equal to or higher than those in
Spain and Turkey, where sun is plentiful [7,24,25]. In Fin-
land low 25(OH)D concentrations were reported in win-
ter, although vitamin D dietary intake recommendations
were met in the studied population [26]. Since then, dairy
fortification has been implemented also in Finland. There
are few population-based studies looking at seasonal dif-
ferences of vitamin D concentrations and no data is avail-
able on vitamin D status of the Estonian population,
which is one of the northernmost non-fortifying Euro-
pean countries [7,14,18,26-33]. The aim of the current
study was to investigate vitamin D status and its seasonal




The study was conducted in Väike-Maarja municipality in
Estonia in 2006. Study subjects were randomly selected
from the registers of general practitioners in the region. An
initial invitation and a second invitation (if needed) were
sent to a total of 402 subjects to participate in the study.
Of those invited, 243 (60%) responded. The non-
responders were substituted once with the next person of
the same age and sex from the patient register, in order to
retain the population structure of the first selection. A
total of 158 substitutions were made and an invitation
(and a repeat if needed) was sent to them. An additional
124 subjects responded (response rate 79%) and were
included in the study. A total of 367 subjects (200 women
and 167 men, aged 25–70 years) participated in the study
with a response rate of 66%. No inclusion/exclusion crite-
ria were applied. An informed consent was obtained from
all the subjects who participated. The Ethics Committee of
Tartu University approved the study. All the 367 respond-
ers were subsequently invited to a follow-up blood test in
the end of summer. Of the 367 subjects 316 (86%) com-
plied and a second blood sample was taken in September.
Self-reported summertime sunbathing habits and for
women menopausal status were recorded with a self-
administered questionnaire. The former was categorised
as: usually bathes the whole body; bathes only the arms
and face or avoids bathing totally. In addition, the use of
vitamin D supplements was recorded. Subject weight and
height were measured for body mass index (BMI; kg/m2)
calculation.
Laboratory measurements
Fasting overnight blood samples were obtained twice dur-
ing the year, in winter (sampling time from January to
March) and in the end of summer (September). All the
samples were taken after overnight fasting between 8 AM
and noon using pre-cooled tubes. Serum was separated
and the samples stored at -20°C until analysed. The serum
25(OH)D level was measured in duplicates by radioim-
munosorbent assay by DiaSorin (former Incstar), Stillwa-
ter, Minnesota, USA. The intra- and interassay CVs were
4.1% and 5.7%, respectively. For group discrimination,
we used 25 nmol/L as the critical value for deficiency and
50 nmol/L as the cut-off value for insufficiency. 75 nmol/
L was considered to be the optimal 25(OH)D level. Serum
PTH was measured with an Immulite 2000 analyser
(DPC). The intra- and interassay CVs were 10.5% and
8.2%, respectively.
Statistics
The variables were verified for normality (Shapiro-Wilk
test) and skewed variables (vitamin D in summer, PTH in
winter and in summer) transformed using a natural loga-
rithm for analysis. However geometric means are pro-
vided for better interpretation in the text. Student t or
Mann-Whitney tests or analysis of variance (ANOVA)
with Tukey test procedure were used to compare means.
Correlations between variables were tested using the Pear-
son product-moment correlation test and presented as
Pearson correlation coefficient (rp). A 5% probability forPage 2 of 8
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0.05). The relationships between serum 25(OH)D con-
centration and PTH in summer were studied with the
nonlinear least-squares regression method for optimal
vitamin D cut-off determination. The locally weighted
polynomial regression modelling (LOWESS) was used to
model the winter PTH and vitamin D data. Determinants
of 25(OH)D were studied using the multiple linear regres-
sion method with backward selection using 25(OH)D
(models for summer and winter separately) as the
dependent variable. The initial variables included in the
regression analysis were age, gender, BMI, fresh milk con-
sumption (as dL/day), other milk product consumption,
caffeinated and alcoholic beverage consumption, smok-
ing (both as a factor and number of cigarettes/day), vita-
min D supplement usage, sun-bathing habits and
menopausal status (in women). All variables with p < 0.1
were included in the final models. Statistical analysis was
performed using the R software package version 2.7.0 (R:
A language and environment for statistical computing. R
Foundation for Statistical Computing, Vienna, Austria).
Results
The mean age of the study group was 48.9 ± 12.2 years
(range 25–70 years). All participants were mobile, com-
munity dwelling Estonians and Caucasians by race. The
study group characteristics are outlined in Table 1.
The mean 25(OH)D concentration in winter was 43.7 ±
15.0 nmol/L (17.2 ± 5.9 μg/L). A significant increase was
observable in 25(OH)D concentration in summer to 59.3
± 18.0 nmol/L (23.3 ± 7.1 μg/L) (p < 0.0001). The average
increase of 25(OH)D for men was 17.9 nmol/L (relative
increase 40%) and for women 13.4 nmol/L (30%), result-
ing in a difference in seasonal increase of 4.5 nmol/L (p =
0.01, 95% CI 0.6–8.2). Gender difference in the seasonal
parathyroid hormone change was not significant. Eight
subjects (2%), all women, were regularly using vitamin D
supplements (over the counter vitamin D or cod-liver oil;
200–800 IU of vitamin D/day). Those subjects taking sup-
plements had a higher serum concentration of vitamin D
in winter (53.9 nmol/L in supplementers vs. 43.5 nmol/L
in non-supplementers, p = 0.053).
Eight percent (n = 29) of subjects had vitamin D defi-
ciency in winter, with equal gender distribution (15
women and 14 men). In summer less than 1% (n = 2; a
single woman and a man) were still vitamin D deficient.
In winter 73% of subjects (133 men and 135 women) had
25(OH)D level under 50 nmol/L, indicating insufficiency.
In summer 29% (n = 93) of subjects were vitamin D insuf-
ficient. In winter 97% and in summer 87% of the subjects
were below the optimal vitamin D level of 75 nmol/L
(Figure 1). The mean 25(OH)D in winter for subjects
refusing the follow-up in summer was lower (39.9 nmol/
L) than that for subjects with both samples performed
(44.4 nmol/L, p < 0.05).
Serum PTH had a strong negative correlation with
25(OH)D concentrations both in winter and in summer
(rp = -0.18 and rp = -0.19 respectively, p < 0.001). In sum-
mer the nonlinear least-squares regression shows an
approximate cut-off value (PTH reaches a plateau) for
25(OH)D around 80 nmol/L in both younger (aged
under 50 years) and older individuals (50 years and
above). In winter there is no plateau effect in either of the
age groups and PTH persists to decline even around the
highest vitamin D values measured in the period (Figure
2). Hyperparathyroidism was present in 23 patients in
winter (15 women and 8 men, mean 25(OH)D 35.9
nmol/L) and in 15 subjects in summer (8 women and 7
men, mean 25(OH)D 42.8 nmol/L). In winter 74% (17 of
23) and in summer 80% (12 of 15) were aged 50 or over.
In winter 78% (18 out of 23) of the subjects with hyper-
parathyroidism were vitamin D insufficient and 26% (6/
23) were vitamin D deficient. In summer 50% of these
subjects were vitamin D insufficient, but none showed
serum levels of deficiency. Three of the subjects with
hyperparathyroidism had the condition persistent
throughout the year.
There was a difference in the 25(OH)D level in summer
between pre- and post-menopausal women (55 nmol/L
Table 1: Characteristics and vitamin D status indicators of the study group (mean +/- SD).
Females (n = 200) Males (n = 167)
Mean SD Mean SD p value
Age 49.2 12 48.5 11.6 NS
BMI 28.5 6.9 27.9 4.6 NS
25(OH)D winter (nmol/L) 44.6 15.8 42.7 14.0 NS
PTH winter (pmol/L) 4.3 1.8 3.8 1.9 p < 0.05
25(OH)D summer (nmol/L)* 58.4 17.7 60.5 18.5 NS
PTH summer (pmol/L)* 3.9 1.7 3.6 1.7 NS
* n = 316; 138 males, 178 femalesPage 3 of 8
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Age also correlated negatively with 25(OH)D only in the
summer (p = 0.016). Both these associations lost signifi-
cance in regression analysis if adjusted for self-reported
sunbathing habits. The 25(OH)D level was strongly
dependent on sunbathing habits both in summer and in
winter (Table 2).
The BMI and 25(OH)D correlated inversely: subjects with
high BMI (>30) had lower 25(OH)D than subjects with a
BMI under 30 (41.0 nmol/L vs. 44.8 nmol/L; p < 0.05). If
a BMI cut-off point of 34 was used the difference was even
more obvious (38.8 nmol/L vs. 44.5 nmol/L; p < 0.01). In
multiple-regression analysis when adjusting for sunbath-
ing habits BMI lost significance in winter. In analysis of
variance (ANOVA) body mass index was significantly
higher in the subjects who avoided sunbathing, and those
who bathed the arms and face only when compared with
total body exposers (p < 0.0001). Younger individuals
were considerably more likely to sunbathe the whole
body than older individuals (p < 0.0001).
Sunbathing habits (p < 0.0001), smoking (p = 0.008) and
vitamin D supplement usage (p = 0.07) were the signifi-
cant determinants of winter vitamin D level in multiple
regression analysis explaining 12% of its variance (r2 =
0.12). In summer the determinants for vitamin D levels
were sunbathing (p < 0.0001), smoking (p = 0.001) and
BMI (p = 0.03) explaining 18% of its total variance (r2 =
0.18).
Discussion
The study is one of the few population-based studies on
vitamin D status in northern Europe. The mean 25(OH)D
in winter is well below 50 nmol/L, with only a third of the
Estonian population showing sufficient vitamin D levels
and just 3% of the population above the optimal level.
Although the mean 25(OH)D level was around 60 nmol/
The distribution of serum 25(OH)D in winter and in summerFigure 1
The distribution of serum 25(OH)D in winter and in summer.Page 4 of 8
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ciency, the majority of the subjects (around 90%) still
stayed below the optimal level of 75 nmol/L. The finding
is similar to the results of other studies in the region dem-
onstrating that the summer build-up of 25(OH)D is inad-
equate in northern countries [26].
For overview purposes the currently available vitamin D
status data in similar populations performed to date is
given in Table 3. Due to the inter-assay and also inter-lab-
oratory variability of different vitamin D measurement
techniques some caution is advocated in interpretation
[34]. At 44 nmol/L the winter mean 25(OH)D concentra-
tion in Estonia is comparable with levels in several south-
25(OH)D plotted against serum PTH concentrationFigure 2
25(OH)D plotted against serum PTH concentration: a) winter, age under 50 years; b) summer, age under 50 years, c) 
winter, age 50 and above; d) summer, age 50 and above.Page 5 of 8
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vitamin D levels in Belgium, France, Switzerland and the
US [7,7,14,18,26,29-33] (Table 3). Our summer
25(OH)D is the lowest in this comparison, which corre-
sponds well with the latitude effect. The fact that there is a
low proportion of vitamin D supplement users in Estonia
and the diet here is also scarce in natural sources of vita-
min D (such as fish or fish products) [35] makes the pop-
ulation largely dependent on the vitamin D stores
accumulated during the sunny season. In a country popu-
lating an even higher latitude, Norway, a study showed
that 40% of the population regularly uses cod-liver sup-
plements, almost 60% consumes fish liver products and
57% other vitamin D supplements, beside cod liver oil
[36]. This might explain why Norway, despite being
located at 65–71 N is one of the countries with the highest
vitamin D levels in Europe.
The proportion of 25(OH)D deficiency and insufficiency
in our study population is comparable with other coun-
tries (table 3) during different seasons even though it is
geographically the highest northern country in the com-
parison after Finland. However we consider the percent-
ages too high to be satisfactory, as there is still a large
proportion of the population who especially during win-
ter are at an increased health risk. Addressing these short-
comings is important as the health risks include diseases
like osteoporosis, rickets and with some evidence support-
ing benefits or risk reductions also for several types of
Table 2: Mean 25(OH)D according to sunbathing habits.
25(OH)D in summer (nmol/L) 25(OH)D in winter (nmol/L)
N* Mean SD N* Mean SD
Avoids sun 36 44.7 1.9 40 33.5 1.9
Arms/face 66 54.7 2.0 78 40.6 1.5
Whole body 206 63.1 1.3 240 46.3 1.0
P value (ANOVA) P < 0.0001 P < 0.0001
Arms/face vs. avoids sun† 10.1 (1.8–18.3); p = 0.01 7.0 (0.5–13.6); p = 0.03
Whole body vs. avoids sun† 18.4 (11.2–25.6); p < 0.001 12.8 (7.1–18.6); p < 0.001
Arms/face vs. whole body† 8.4 (2.7–14.0); p = 0.001 5.8 (1.4–10.1); p = 0.006
* 10 subjects did not provide their sun-bathing habits data
† Post-hoc analysis using Tukey test; presented as differences in mean (95% CI); p value
Table 3: 25(OH)D status in population studies of adults (15+) in the order of latitude.










summer winter summer winter summer winter
New Zealand 
[30]
35–47S RIA Diasorin 2946 1:1,400 67 44 0–10 48
Japan [31] 35 N RIA Disaorin 197 1:647,000 79 38 ND ND 1 87
US [32] 25–47 N RIA Disaorin 18462* 1:16,200 62–90 60–79 1–3 1–5 8–34 13–40
Italy [14] 40 N RIA Disaorin 90 1:645,000 84 43 2 ** 18 ** 4 70
Switzerland 
[33]
46–47 N CPB 
Amersham
3276 1:2,300 ND 50 † ND 6 † ND 34–95 †
France [7] 43–51 N RIA Incstar 1569 1:39,000 ND 61 (43–94) ND 14 ** ND 75 ***
Germany 
[29]
49 N RIA Incstar 415 1:199,000 67–70 40–45 ~5 †† 30–40 ND ND
Belgium [18] 50 N ChL Diasorin 126 1:82,000 ND 48 ND ND ND 34 †††
Estonia 59 N RIA 
Disaorin
367 1:3,600 59 44 <1 8 29 73
Finland [26] 60 N RIA Incstar 328 1:16,000 ND 46 ND 26–28 ND 56–86 ***
* Two different seasonal sub-populations; ** level of <30 nmol/L used to define deficiency; *** own specific cut-off for insufficiency (based on PTH 
curve) was used; † data from October to June (no summer months); †† no official data in paper (calculated from a figure); ††† level of <37.5 nmol/
L was defined as insufficient; ND – no data.Page 6 of 8
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sclerosis [1-4].
Our study supports the evidence that PTH achieves a pla-
teau at 25(OH)D concentrations between 75 and 90
nmol/L demonstrated recently [21]. In winter no plateau
was achieved, since the majority of observations (97%)
were below 75 nmol/L.
Our study demonstrated an unexpected finding that men
have a higher amplitude of 25(OH)D variance through
the seasons than women. Clothing habits have been
shown to influence 25(OH)D levels [11,37]. There might
be gender-specific clothing differences (although not of a
culture-religious nature in the studied region) which are
responsible for a higher 25(OH)D in men after the sunny
season. There is also a possibility that men are more likely
to work outside during the summer than women, result-
ing in longer exposure to UV light. Secondly, fat tissue is
the physiological depot for vitamin D suggesting that the
obese have an increased storage capacity of 25(OH)D
[38,39]. The fact that with equal BMI and age, men have a
lower body fat percentage than women [40] might explain
the faster decline and also the faster accrual in men. Stud-
ies have also shown that vitamin D has a role in neu-
romuscular function [41,42]. This might mean that men,
having higher muscle mass and lower fat tissue [40],
require more vitamin D to sustain muscle cell function
and in the absence of UVB radiation, deplete their vitamin
D stores faster.
The study showed that BMI, age and menopause deter-
mined 25(OH)D status in the end of summer, but not in
winter. The fact that all these associations lost significance
when adjusted for sunbathing habits suggests that most
probably it is not the weight and age per se influencing
25(OH)D, but their effect on sunbathing, which impacts
the UVB doses they are subjected to in summer, resulting
in lower 25(OH)D levels. This is plausible, as we found
no correlation between 25(OH)D and BMI, age or meno-
pausal status (an indirect indicator of age for women) in
winter, when these factors cannot exert their effect on sun
exposure.
As a study limiting factor we might be reporting 25(OH)D
values, which are slightly higher than the average year to
year measurements at this latitude, as in summer 2006 the
sun was comparatively plentiful compared to previous
years. In our study people with a higher 25(OH)D value
in winter were more likely to attend the follow-up test in
summer, which is another minor aspect of bias. Therefore
it is possible that we might be overestimating vitamin D
levels in summer. However, since the drop-out rate was
not remarkable, this bias should not influence the results
significantly. At the time of the study our laboratory was
not part of the international vitamin D assays quality
assessment scheme (DEQAS) which, as already men-
tioned, would have enhanced the comparability of the
results with those performed by other laboratories and
assay methods.
Conclusion
We demonstrated that 25(OH)D levels are low all year
round in Estonia, a country situated at a high northern lat-
itude. Dairy fortification with vitamin D (which is already
practiced in neighbouring Finland, Norway, Sweden and
also the US) might address these shortcomings in addi-
tion to propagating healthy sunbathing habits, since sun
had a major effect on vitamin D status and explained
much of the age and BMI caused variance in 25(OH)D
levels.
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